Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Moreno

Showing results (321-330 of 400) with videos related to

Pageof 40
Sort By:
Journal of the American Academy of Dermatology|January 17, 2017
Internet-based skin cancer screening using clinical images alone or in conjunction with dermoscopic images: A randomized teledermoscopy trialLara Ferrándiz, Teresa Ojeda-Vila, Araceli Corrales, et al.
Elife|June 10, 2020
Modulation of dopamine D<sub>1</sub> receptors via histamine H<sub>3</sub> receptors is a novel therapeutic target for Huntington's diseaseDavid Moreno-Delgado, Mar Puigdellívol, Estefanía Moreno, et al.
Frontiers in Molecular Biosciences|April 27, 2026
Sex-based antibody subclass maturation drives direct enzymatic inhibition in fabry disease patients receiving enzyme replacement therapyTomas Baldwin, Hibba Kurdi, Ivan Doykov, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 2015
Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaineGemma Navarro, César Quiroz, David Moreno-Delgado, et al.
JAAD International|August 19, 2021
Feasibility and cost of a telemedicine-based short-term plan for initial access in general dermatology in Andalusia, SpainRuben Barros-Tornay, Lara Ferrándiz, Francisco J Martín-Gutiérrez, et al.
The Pediatric Infectious Disease Journal|July 26, 2012
High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmissionVerónica Briz, Dolores García, Gema Méndez-Lagares, et al.
Journal of Medicinal Chemistry|July 30, 2024
Identification of the Clinical Candidate <b>PF-07284890</b> (<b>ARRY-461</b>), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of CancerLi Ren, David Moreno, Brian R Baer, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2012
The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinaseLi Ren, Kateri A Ahrendt, Jonas Grina, et al.
Anales De Pediatria|July 30, 2018
[Child hospital admissions associated with influenza virus infection in 6 Spanish cities (2014-2016)]Javier Arístegui Fernández, Eduardo González Pérez-Yarza, María José Mellado Peña, et al.
AIDS (London, England)|November 7, 2015
Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practiceClaudia Palladino, María Luisa Navarro Gómez, Pere Soler-Palacín, et al.
Pageof 40

Showing results (321-330 of 400) with videos related to

Sort By:
Pageof 40
Journal of the American Academy of Dermatology|January 17, 2017
Internet-based skin cancer screening using clinical images alone or in conjunction with dermoscopic images: A randomized teledermoscopy trialLara Ferrándiz, Teresa Ojeda-Vila, Araceli Corrales, et al.
Elife|June 10, 2020
Modulation of dopamine D<sub>1</sub> receptors via histamine H<sub>3</sub> receptors is a novel therapeutic target for Huntington's diseaseDavid Moreno-Delgado, Mar Puigdellívol, Estefanía Moreno, et al.
Frontiers in Molecular Biosciences|April 27, 2026
Sex-based antibody subclass maturation drives direct enzymatic inhibition in fabry disease patients receiving enzyme replacement therapyTomas Baldwin, Hibba Kurdi, Ivan Doykov, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 2015
Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaineGemma Navarro, César Quiroz, David Moreno-Delgado, et al.
JAAD International|August 19, 2021
Feasibility and cost of a telemedicine-based short-term plan for initial access in general dermatology in Andalusia, SpainRuben Barros-Tornay, Lara Ferrándiz, Francisco J Martín-Gutiérrez, et al.
The Pediatric Infectious Disease Journal|July 26, 2012
High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmissionVerónica Briz, Dolores García, Gema Méndez-Lagares, et al.
Journal of Medicinal Chemistry|July 30, 2024
Identification of the Clinical Candidate <b>PF-07284890</b> (<b>ARRY-461</b>), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of CancerLi Ren, David Moreno, Brian R Baer, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2012
The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinaseLi Ren, Kateri A Ahrendt, Jonas Grina, et al.
Anales De Pediatria|July 30, 2018
[Child hospital admissions associated with influenza virus infection in 6 Spanish cities (2014-2016)]Javier Arístegui Fernández, Eduardo González Pérez-Yarza, María José Mellado Peña, et al.
AIDS (London, England)|November 7, 2015
Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practiceClaudia Palladino, María Luisa Navarro Gómez, Pere Soler-Palacín, et al.
Pageof 40